Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Oasmia Pharmaceutical AB | 1,350,000 | net | 19 Dec 2021 | tx 1+1,350,000 |
| Karolinska Development AB | 95,000 | net | 03 Jun 2020 | tx 3+95,000 |
| KK Invest AB | -70,000 | net | 30 Nov 2016 | tx 2+20,000−90,000 |
| Bactiguard B.V. | -40,000 | net | 30 Nov 2016 | tx 1−40,000 |
| Orexo AB | 29,683 | net | 19 May 2025 | tx 7+29,683 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 May 2025 | GRANT_AWARD | Orexo AB | 13,433 | 0.00 SEK | |
| 04 Apr 2025 | PURCHASE | Orexo AB | 2,000 | 13.68 SEK | first after silence |
| 26 Mar 2024 | PURCHASE | Orexo AB | 3,000 | 14.68 SEK | |
| 08 Nov 2023 | PURCHASE | Orexo AB | 1,500 | 15.81 SEK | |
| 27 Mar 2023 | PURCHASE | Orexo AB | 2,250 | 15.31 SEK | |
| 06 Nov 2023 | PURCHASE | Orexo AB | 3,000 | 15.08 SEK | |
| 27 Jan 2023 | PURCHASE | Orexo AB | 4,500 | 17.71 SEK | first after silence |
| 19 Dec 2021 | GRANT_AWARD | Oasmia Pharmaceutical AB | 1,350,000 | 0.00 SEK | deriv |
| 03 Jun 2020 | PURCHASE | Karolinska Development AB | 50,000 | 2.98 SEK | |
| 20 Dec 2019 | PURCHASE | Karolinska Development AB | 30,000 | 3.30 SEK | |
| 15 Feb 2019 | PURCHASE | Karolinska Development AB | 15,000 | 6.40 SEK | first after silence |
| 30 Nov 2016 | SALE | KK Invest AB | 90,000 | 6.73 SEK | |
| 30 Nov 2016 | PURCHASE | KK Invest AB | 20,000 | 10.16 SEK | |
| 30 Nov 2016 | SALE | Bactiguard B.V. | 40,000 | 6.73 SEK |
3 purchases reported after at least 12 months of silence — most recent on 04 Apr 2025.